Background and Purpose: A benefit of miniaturized percutaneous nephrolithotomy (MPCNL) compared with conventional percutaneous nephrolithotomy (PCNL) has not been demonstrated as yet. Thus, the aim of this study was to evaluate the outcome of conventional vs MPCNL and to determine if MPCNL offers an advantage for the patient. Patients and Methods: A prospective, nonrandomized series of 50 consecutive patients with solitary calculi (lower pole or the renal pelvis) were treated either by conventional PCNL (26F) or MPCNL (18F). Ultrasound or holmium laser were used for lithotripsy. Patients were treated tubeless after uncomplicated MPCNL, with thrombin-matrix tract closure and antegrade Double-J catheter placement. After PCNL, all patients received 22F nephrostomies. Demographic data, stone characteristics, perioperative course, and complication rates were assessed. Results: Patients characteristics were comparable in both groups, except for stone size, which was 18 AE 8 mm (MPCNL) and 23 AE 9 (PCNL; P ¼ 0.042). Operative time was comparable in both groups (48 AE 17 vs 57 AE 22 min, not significant [NS]). After MPCNL, 96% were stone free at day 1 vs 92% after PCNL (NS). Significant complications did not occur in both groups. Minor complications were: Fever, 12% (MPCNL) vs 20% (PCNL; NS); bleeding, 4% vs 8%; perforations, 0% vs 4% (all NS). Overall outcome was not influenced by body mass index. Calcium oxalate stones were predominant with 75%. Patients after tubeless MPCNL had less pain (visual analogue score, 3 AE 3 vs 4 AE 3; P ¼ 0.048.) and needed slightly less additional pain medication (25 AE 12 mg=d vs 37 AE 10 mg=d piritramid; NS). Hospital stay was significantly shorter after MPCNL (3.8 AE 28 vs 6.9 AE 3.5 d; P ¼ 0.021.). Conclusions: Both techniques were safe and effective for the management of renal calculi. While stone-free rates were comparable in our series, MPCNL showed advantages in terms of shorter hospital stay and postoperative pain. The lower stone burden and the tubeless fashion of MPCNL, however, might have influenced these results.
Introduction
U rolithiasis is a widespread disease, with approximately 750,000 cases per year in Germany.
1,2 Of urinary stone formers, 25% have recurrent stone formation.
3 Therefore, urolithiasis has a significant impact on life quality and socioeconomic factors.
Percutaneous nephrolithotomy (PCNL) is recommended as standard therapy for kidney stones >20 mm, while shockwave lithotripsy (SWL) is recommended for smaller renal calculi. 4, 5 The stone clearance of lower-pole calculi after SWL is limited, however, thus leading to an extended indication for
Percutaneous nephrolithotomy (PCNL) represents the gold standard for the management of large renal calculi due to its stone-free rate of more than 90% independent of stone size, location or composition [1] [2] [3] [4] [5] . The morbidity associated with PCNL is acceptable for the majority of patients [5] [6] [7] . However, the low but signiWcant rate of major complications include acute renal loss, chronic renal failure and prolonged urine leakage [7] .
However, for a certain group of patients with large renal stones, PCNL is not considered to be the ideal treatment [8, 9] . The indication for a diVerent surgical approach (e.g., retrograde ureteroscopic treatment) of large upper urinary tract calculi includes morbid obesity (i.e., body mass index > 30), bleeding diathesis, severe cardiopulomonary disease, certain anatomic factors such as severe kyphoscoliosis and renal ektopia and the inability to tolerate the potential morbidities and/or complications of PCNL, as well as failed prior PCNL [8] [9] [10] .
A new generation of Xexible ureteroscopes with reduced distal tip and midshaft size are now widely available. Compared to their predecessors access to the complete upper urinary tract in up to 94% of cases is facilitated [11] . Due to these improvements the therapeutic role of ureteroscopic treatment is may be extended.
Results
Within the last twelve months 27 out of 362 patients treated by ESWL necessitated stone disintegration with the holmium laser using in 22 of cases rigid and in five cases flexible uretero-renoscopies.
Stone Location
· upper calyx 2 · mid calyx 1 · lower calyx 3 · proximal and mid ureter 17 and 4 cases respectively
In 74 percent of the cases stones were composed to more than 80 percent of ca-oxalate monohydrate. The laser energy ranged from 600 to 1400 mJ with an average number of 2589 pulses.
With 25 patients (93 percent) complete disintegration into fragments < 3 mm was achieved. In two cases the partial disintegration of stones (19 and 18 mm) was completed by ESWL. A retro-grade migration of the stone was not observed.
Ureter perforation occurred in two cases. In one of them the lesion was attributed directly to the cutting effect of laser. All complications were healed by stent placement for four until six weeks. Postoperatively one patient became fever over 38,5 °C and was cured with antibiotics. There were no severe intra-or postoperative complication. The average postoperative stay in hospital was 1,8 days.
Conclusions
The holmium laser appears to be an effective and safe tool for endoscopical treatment of stones resistant to ESWL shock wave therapy. Taking into account that in 93 percent of cases the sufficient disintegration even of the hardest ca-oxalate monohydrate stones could be achieved within one single session, we would recommend this method for routine clinical use.
Care should be taken to avoid the direct contact of the laser probe with the ureteral tissue. 
Summary
Aholmium laser is a pulsed laser system with a wavelength of approximately 2 µm with absorption properties midway between those of a Nd:YAG laser and a CO2 laser.
By choosing suitable laser parameters, the laser can easily be adapted to the application intended. It is equally suitable for athermal ablation of hard and soft tissues and for lithotripsy, regardless of the color or composition of the calculus.
In particular medium-power (30 _ 40 W) holmium laser units are ideally suited for today's endourology thanks to their wide range of applications, their effective and safe use, and their comparably favorable capital investment requirements and running costs.
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Introduction: Characteristics of Holmium Lasers
For some years now holmium lasers have been available for endourological applications [1, 2] . Like the Nd:YAG laser the holmium is a solid-state laser operating in the infrared segment of the spectrum, except that its wavelength of 2 µm is twice as much of an Nd:YAG laser of 1 µm.
While Nd:YAG lasers are characterized by low water absorption and their ability to deeply penetrate the tissue, the wavelength of the holmium laser beam is easily absorbed by water, so its depth of penetration, at approximately 0.4 mm, is therefore low. Being a pulsed laser with a pulse duration of several hundred microseconds and high absorption in tissue, the effect of a holmium laser is restricted to the area close to the fiber tip. It creates a minimal zone of coagulation around the treatment area of approximately 0.5 mm _ large enough to prevent bleeding in most cases and to facilitate hemorrhage-free procedures. A satisfactory cutting effect can be achieved by using repetition rates starting at 15 _ 20 Hz. Furthermore, the water content of uroliths and other calculus turned out to be high enough for adequate energy absorption; therefore calculi can be destroyed regardless of their color, hardness, or composition. 
Introduction
The first laser introduced for endourological applications was the Nd:YAG laser in the early eighties. At that time only the Nd:YAG laser was available with power levels high enough for surgical applications and a wavelength (1064 nm) that could be transferred through highly flexible quartz-fibers necessary for endoscopic applications.
First introduced for many different applications, its main application is still its ability to coagulate relativly large volumes of tissue e.g. when coagulating bladder tumors or genital warts. With additional tricks (blackening of fiber tip, electro optic feedback system "fibertom") it can be used for cutting tissue (e. g. urethral strictures) too, but due to its low absorption in tissue, due to a correspondingly deep penetration and being a continuously emitting laser it shows large thermal side effects, which are not limited to the actual application site, but go far beyond it. The overall benefit of this laser type reduced these side effects considerably.
Any attempts to use this type of laser for lithotripsy failed just as the absorption of the stones was too low or the power transmission capability of the fibers was insufficient when running the laser in the q-switched mode.
1985 the flashlamp pumped dye laser was introduced. Though being effective in destructing different types of stones, these lasers proved out to be expensive tools regarding the initial investment and the running costs as the laser medium, a coloured liquid, had to be changed frequently. Nevertheless, staying competitive a urological clinic of high standing had to offer both laser types.
However, one was hoping the laser industry would be able to offer an affordable laser system based on solidstate laser technology that can be used for a large variety of endourological applications, with high efficacy and safety in application.
Holmium Laser
For a couple of years the holmium laser has been offered for endourological applications. Its wavelength (2100 nm) is very well absorbed by water. As water is the main constituent of tissue it can easily be vaporized by this holmium laser. As it is a pulsed laser its emission consists of short pulses with a duration of several hundred microseconds. When applied to a high repetition rate a nice cutting effect can be established. Due to its high absorption in tissue and its short pulse duration, the effect of the holmium laser pulses applied is limited to the area close to the tip of the fiber. Nevertheless, it still creates a small coagulation zone surrounding the vaporized area thick enough to prevent bleeding in most cases. Furthermore, it has been proved that the water content of urinary stones was high enough to yield enough absorption for destructing all types of stones regardless of colour, composition, and hardness. Ultrasonic lithotripsy is a standard treatment modality used during PCNL because of its ability to simultaneously fragment stones and clear the resulting fragments with minimal tissue injury thanks to its simultaneous suction. When confronted with harder stones, ballistic lithotripters can be more effective while also minimizing tissue injury. However, time-consuming extraction of fragments with graspers after stone disintegration can limit its efficacy. Electrohydraulic lithotripsy can cause significant tissue trauma and all fragments must be grasped and extracted.
Since the introduction of the holmium:yttrium-aluminumgarnet (Ho:YAG) laser into clinical practice in 1990, it has been used successfully to treat various urologic conditions. 1 Today it is the modality of choice for retrograde intracorporeal stone disintegration ureteroscopically, and has also been used successfully for PCNL. [2] [3] [4] One disadvantage when using the Ho:YAG laser for disintegration of renal calculi is the need for graspers to extract fragments and the mobilization of fragments due to the lack of simultaneous suction. We present our experience with a Ho:YAG laser in combination with simultaneous suction in an in-vitro model using a new endourologic technology in comparison to standard ultrasonic lithotripsy.
Materials and Methods
To evaluate the disintegration we used artificial stones (made of plaster of Paris). Ten stones were used for ultrasonic disintegration (group 1) and 10 stones for were subjected to laser disintegration (group 2). Stones of macroscopically similar size were selected for both groups. After selection, the stones were weighed to guarantee similar weights in both groups.
The specially designed device consists of a 34-cm-long stainless steel tube (14F) with a separate 12F outflow channel for the suction. This steel tube was linked to a micromanipulator (Storz, Tuttlingen, Germany). The device was manufactured specially for our purposes by Storz (Fig. 1) . The micromanipulator allows fixation as well as exact positioning of the laser fiber within the steel tube. The assembly of the laser/suction device was simple and uncomplicated. 
Minimal-invasive PCNL (Mini-Perc)

Introduction
T he advent and continuous evolution of percutaneous nephrolithotomy (PCNL) have led to a revolution in the management of renal stones.
1,2 PCNL is now the mainstay of treatment for patients with renal calculi and is a safe and successful method used for removal of different types of stones.
3 Several modifications and refinements in nephroscopes have improved observation, and the use of slender nephroscopes has further enhanced the outcome and decreased the morbidity. 4 In the present study, minimally invasive tract in PCNL (Mini-PCNL) is defined as a PCNL technique with small working sheath, which is performed using an 8=9.8F ureteroscope through a 16F percutaneous renal access tract. It seems that using a smaller-sized percutaneous tract than the standard PCNL has the potential advantage of decreased bleeding and trauma to renal parenchyma, which may effectively reduce intraoperative and postoperative complications. 5, 6 However, no study is available to consider and compare the clinical curative effect of Mini-PCNL. We have performed a randomized comparison of Mini-PCNL with the standard PCNL to evaluate the efficacy, safety, and morbidity of Mini-PCNL for renal stones.
Patients and Methods
Between May 2004 and December 2007, 287 patients undergoing PCNL were incorporated into this randomized study at our center, including 142 in the Mini-PCNL group and 139 in the standard PCNL group. One hundred eighty patients (98 men and 82 women) who met the inclusion Introduction T he advent and continuous evolution of percutaneous nephrolithotomy (PCNL) have led to a revolution in the management of renal stones.
Between May 2004 and December 2007, 287 patients undergoing PCNL were incorporated into this randomized study at our center, including 142 in the Mini-PCNL group and 139 in the standard PCNL group. One hundred eighty patients (98 men and 82 women) who met the inclusion
